Auto antibodies to GLDN have been detected in other chronic demyelinating conditions such as multiple sclerosis (MS) involving the CNS and in particular chronic inflammatory demyelinating polyradiculoneuropathy involving the peripheral nervous system (Kira et al., 2019). Here, GLDN is linked to chronic inflammatory demyelinating polyradiculoneuropathy.